FDA approves ARIES HSV 1&2 Assay for Herpes simplex diagnostics- Luminex Corp
Luminex Corporation has received FDA clearance for the company's ARIES System and ARIES HSV 1&2 Assay for Herpes simplex. Clinical trials for the ARIES C. difficile Assay and the ARIES Group B Streptococcus (GBS) Assay are progressing, and the company expects to launch clinical trials for additional ARIES products.
ARIES uses internal barcode scanning and other features to minimise operator errors. Two independent magazine modules each support from one to six cassettes, allowing for both stat and batch testing. Simultaneous IVD and Laboratory Developed Tests (LDTs) can operate through a common Universal Assay Protocol.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.